Skip to main content

Dale Pfost, Donald Marvin, Klaus Schollmeier, Tristan Orpin

Premium

Dale Pfost has resigned as president and CEO of Orchid BioSciences of Princeton, N.J., and Donald Marvin has resigned as senior vice president and general manager, the company announced this week. Orchid has established a search committee to find a replacement for Pfost who is leaving to pursue other opportunities. Pfost was chairman of the company from November 1996 to September 2002.

Klaus Schollmeier has been appointed chief executive officer of Graffinity Pharmaceuticals of Heidelberg, Germany, effective Jan. 1, 2003. Schollmeier most recently served as managing director of the healthcare/biotechnology group at ING-BHF Bank and previously held senior management positions at BASF Pharma. Schollmeier holds a PhD in biology from the University of D sseldorf and has been an adjunct research associate professor at Boston University Medical School.

Tristan Orpin was named vice president of worldwide sales for San Diego-based Illumina, the company announced last week. Orpin, formerly vice president for sales and marketing for Sequenom, will head sales of BeadArray and Oligator technology for Illumina. Previously, Orpin worked in sales for Bio-Rad Laboratories where he was Australasian general manager for the company’s life sciences division. Orpin has a BS degree in biochemistry from the University of Melbourne, Australia.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.